Dr. Harry J. Wasvary, MD

Dr. Wasvary practices at Harry Wasvary, M.D. in Royal Oak, Michigan.

Dr. Wasvary's NPI, 1952383150, was assigned on November 15, 2005. Dr. Wasvary graduated from Wayne State University School Of Medicine in 1992. Dr. Wasvary holds Michigan license 4301059778.

Dr. Wasvary's primary practice is Harry Wasvary, M.D., at 1121 Crooks Rd, Royal Oak, MI 48067 in Oakland County. The practice phone is (248) 514-8554.

Dr. Wasvary's primary practice is Harry Wasvary, M.D. in Royal Oak, Michigan. Dr. Wasvary is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Wasvary to 3 more hospitals, 1 physician office, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wasvary practices, 7 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Wasvary's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Wasvary is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dr. Wasvary is licensed in Michigan.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Wasvary treats.

CMS data shows 963 Medicare services from Dr. Wasvary across 13 procedure codes in 2024, for 632 Medicare patients. Medicare paid $102,165 for them.

CMS counts 632 Medicare patients who saw Dr. Wasvary in 2024. The largest group is 65 to 74, with 318 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wasvary's median patient age at 65, with 49% women.

In 2024, Dr. Wasvary wrote 447 Medicare Part D claims for 155 patients. 89% of them were for generic drugs. CMS names the drug for 358 of them, across 10 drugs with 11 or more claims each, at $14,157 in total drug cost. In 2023, CMS named 304 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 29 out of 100 for Dr. Wasvary for performance year 2024, reported individually. Dr. Wasvary accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 204 procedures of colonoscopy by Dr. Wasvary, more than 94% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 31 papers to Dr. Wasvary, published from 2010 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Colectomy, Laparoscopy and Colorectal Neoplasms. Dr. Wasvary has published most often in Am Surg. Dr. Wasvary's most frequent co-authors are Rebecca A. Levine, MD, Marc Grodsky, MD and Samer Kawak, MD.

Dmand AI links Dr. Wasvary to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Rectal Diseases, Colorectal Neoplasms and Colonic Neoplasms. SWOG Cancer Research Network sponsors the most, 2.

CMS Open Payments shows 10 general payments to Dr. Wasvary from 5 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 74% of the total. Intuitive Surgical, Inc. paid the most, $712.

Dmand AI lists 2 awards for Dr. Wasvary, most recently Regional Top Doctor in 2014.

Dr. Wasvary graduated from Wayne State University School Of Medicine in 1992.

Dr. Wasvary is in network with 19 carriers, including Aetna, Elevance and Health Alliance Plan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.